Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
75 patients around the world
Available in United States, Brazil, Spain
AbbVie
4Research sites
75Patients around the world
This study is for people with
Leukemia
Chronic lymphocytic leukemia
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Hospital de Clínicas de Porto Alegre - HCPA/UFRGS
Rua Ramiro Barcelos, 2350, Av. Protásio Alves, 211 - Santa Cecília, Porto Alegre - RS, 90035-903
Instituto de Ensino e Pesquisa São Lucas
São Paulo, Sao Paulo, 01236-030
Hospital Nove de Julho
Rua Peixoto Gomide, 545 - Jardim Paulista, São Paulo - SP, 01409-001, Brazil
